Literature DB >> 30924307

Indications for laparoscopic liver resection of mass-forming intrahepatic cholangiocarcinoma.

Masahiko Kinoshita1, Akishige Kanazawa1, Shigekazu Takemura2, Shogo Tanaka2, Shintaro Kodai1, Hiroji Shinkawa2, Sadatoshi Shimizu1, Akihiro Murata1, Kohei Nishio1, Genya Hamano1, Tokuji Ito2, Tadashi Tsukamoto3, Shoji Kubo2.   

Abstract

INTRODUCTION: We investigated the indications for laparoscopic liver resection (LLR) of mass-forming intrahepatic cholangiocarcinoma (MF-ICC), including the need for lymph node dissection for improved postoperative prognosis.
METHODS: This study involved 36 patients who underwent surgery for solitary peripheral MF-ICC. Fifteen patients underwent LLR, and 21 underwent open liver resection (OLR). Surgical outcomes and prognostic factors were investigated to determine the indications for LLR.
RESULTS: No significant differences were observed in perioperative outcomes between patients who underwent LLR and OLR. A significantly worse disease-free survival (DFS) rate was observed in patients who preoperatively had a tumor diameter ≥3 cm, vascular invasion on diagnostic imaging, and elevated serum carbohydrate antigen (CA) 19-9 and carcinoembryonic antigen (CEA) levels. A significantly worse overall survival (OS) rate was observed in patients with a tumor diameter ≥3 cm, vascular invasion on diagnostic imaging, and elevated serum CA19-9 levels. Therefore, a tumor diameter ≥3 cm, vascular invasion on diagnostic imaging, and elevated serum CA19-9 and CEA levels were determined to be preoperative prognostic factors. DFS and OS rates were significantly better in patients without these factors. Moreover, in six patients without these factors who underwent LLR, neither lymph node metastasis nor postoperative recurrence was observed.
CONCLUSION: A tumor diameter ≥3 cm, vascular invasion on diagnostic imaging, and elevated serum CA19-9 and CEA levels are preoperative prognostic factors for peripheral MF-ICC. LLR is indicated for patients without these factors.
© 2019 Japan Society for Endoscopic Surgery, Asia Endosurgery Task Force and John Wiley & Sons Australia, Ltd.

Entities:  

Keywords:  intrahepatic cholangiocarcinoma; laparoscopic liver resection; lymph nodes dissection

Year:  2019        PMID: 30924307     DOI: 10.1111/ases.12703

Source DB:  PubMed          Journal:  Asian J Endosc Surg        ISSN: 1758-5902


  8 in total

1.  Reply to the Letter: "Laparoscopic Hepatectomy Has Superiority in R0 Resection over Open Hepatectomy for Intrahepatic Cholangiocarcinoma? The Evidence Is Unreliable".

Authors:  Fangqiang Wei
Journal:  J Gastrointest Surg       Date:  2019-12-10       Impact factor: 3.452

2.  Prognostic factors for patients with mass-forming intrahepatic cholangiocarcinoma: A case series of 68 patients.

Authors:  Jian Feng; Bin Liang; Hang-Yu Zhang; Zhe Liu; Kai Jiang; Xiang-Qian Zhao
Journal:  World J Gastrointest Surg       Date:  2022-05-27

3.  Liver Cancer Study Group of Japan Clinical Practice Guidelines for Intrahepatic Cholangiocarcinoma.

Authors:  Shoji Kubo; Hiroji Shinkawa; Yoshinari Asaoka; Tatsuya Ioka; Hiroshi Igaki; Namiki Izumi; Takao Itoi; Michiaki Unno; Masayuki Ohtsuka; Takuji Okusaka; Masumi Kadoya; Masatoshi Kudo; Takashi Kumada; Norihiro Kokudo; Michiie Sakamoto; Yoshihiro Sakamoto; Hideyuki Sakurai; Tadatoshi Takayama; Osamu Nakashima; Yasushi Nagata; Etsuro Hatano; Kenichi Harada; Takamichi Murakami; Masakazu Yamamoto
Journal:  Liver Cancer       Date:  2022-02-23       Impact factor: 12.430

4.  Selection criteria for minimally invasive resection of intrahepatic cholangiocarcinoma-a word of caution: a propensity score matched analysis using the national cancer database.

Authors:  Omid Salehi; Vera Kazakova; Eduardo A Vega; Onur C Kutlu; Sylvia V Alarcon; Richard Freeman; Olga Kozyreva; Claudius Conrad
Journal:  Surg Endosc       Date:  2021-11-08       Impact factor: 3.453

Review 5.  Meta-analysis of laparoscopic versus open liver resection for intrahepatic cholangiocarcinoma.

Authors:  Nikolaos Machairas; Ioannis D Kostakis; Dimitrios Schizas; Stylianos Kykalos; Nikolaos Nikiteas; Georgios C Sotiropoulos
Journal:  Updates Surg       Date:  2020-11-21

Review 6.  Approach to Resectable Biliary Cancers.

Authors:  Kimberly Washington; Flavio Rocha
Journal:  Curr Treat Options Oncol       Date:  2021-09-15

7.  Safety and feasibility of laparoscopic liver resection for patients with large or multiple intrahepatic cholangiocarcinomas: A propensity score based case-matched analysis from a single institute.

Authors:  Yunfeng Zhu; Jiulin Song; Xi Xu; Yifei Tan; Jiayin Yang
Journal:  Medicine (Baltimore)       Date:  2019-12       Impact factor: 1.889

8.  Minimally invasive surgical treatment of intrahepatic cholangiocarcinoma: A systematic review.

Authors:  Renato Patrone; Francesco Izzo; Raffaele Palaia; Vincenza Granata; Guglielmo Nasti; Alessandro Ottaiano; Gilda Pasta; Andrea Belli
Journal:  World J Gastrointest Oncol       Date:  2021-12-15
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.